Treatment of erectile dysfunction of primarily organic etiology. Adjunct to other tests in the diagnosis and management of erectile dysfunction.
The aim of these guidelines is to deliver current evidence-based information on the diagnosis and treatment of patients with primary urethral carcinoma.
Arcutis Biotherapeutics announced the submission of a supplemental new drug application (sNDA) to the FDA for the expanded indication of Zoryve (roflumilast) cream 0.3% for the treatment of plaque psoriasis in children ages 2 to 11
LEO Pharma announced it has submitted a New Drug Application to the FDA for calcipotriene/betamethasone dipropionate aerosol foam 0,005%/0,064% for...
Arcutis Biotherapeutics, Inc. announced the FDA has approved the supplemental new drug application (sNDA) to expand the indication of Zoryve (roflumilast) cream 0.3% for the topical treatment of plaque psoriasis, including intertriginous areas, to children ages 6 to 11 years.
Background: We performed a systematic review and meta-analysis to determine the prevalence and predictors of urethral stricture development post radiation therapy (RT) for prostate cancer (PCa).